The GHC summit at Harvard, is a yearly event designed to catalyze collaborations to eliminate...
There are no announcements yet.
GHC 2018
May 2018, the Cannabis Science team participated in the 2018 Global Health Catalyst Summit held at Harvard Medical School in Boston, MA. The Global Health Catalyst (GHC) summit at Harvard, is a premier yearly event designed to catalyze high impact international collaborations to eliminate global health disparities, with main focus on cancer and related diseases. During this summit Mr. Raymond C. Dabney, the Company’s President, Chief Executive Officer (CEO), and Co-founder was named the recipient of the esteemed 2018 Harvard Global Health Catalyst (GHC) Industry Leader Award and was the keynote speaker during the Phytomedicines Session.
The theme of the Phytomedicines Session was From Farm to Bedside: Advancing Clinical Translation of Medical Cannabis and Other Phytomedicines for Global Health. Mr. Dabney discussed the development of effective cannabinoids and the creation of the Cannabis Science Global Consortium, a research and development framework and platform to cooperate and collaborate with stakeholders worldwide.
Cannabis Science’s Chief Medical Officer (CMO), Dr. Allen Herman, moderated the Phytomedicines Session and also presented on the role of cannabinoids in reducing the pain therapeutic divide between developed and developing countries, and CBIS’ research and development plan.
Pan African Ambassador for Food Security and member of the Cannabis Science Scientific Advisory Board, Dr. Brylyne Chitsunge, discussed opportunities to cultivate, extract, manufacture, package, and distribute cannabinoids in Sub-Saharan Africa along with the task of educating the rest of the continent through actions and success. The Ambassador’s main take away for the audience was the emphasis of the importance of micro-nutrition and food security within the overall approach to improve healthcare outcomes throughout all of Africa.
GHC Europe 2018
Cannabis Science participated in the Europe Global Health Catalyst (GHC) Summit and Summer Workshop in Germany, organized by at the University of Heidelberg and Harvard Medical School’s Global Health Catalyst. CBIS’ Scientific Advisory Board Member and Chief Executive Officer (CEO) of Elpasso Farms in South Africa, Dr. Brylyne Chitsunge, was invited to deliver a keynote address on engaging the African Diaspora, phytomedicines in global health, and closing the cancer pain divide. This two-day event held August 30th and 31st, is a pre-summit to the annual GHC Summit at Harvard Medical School in Boston, Massachusetts, and was attended by government officials, private-sector leaders, and researchers from Europe, the United States, and throughout Africa.
As keynote speaker, Dr. Chitsunge also discussed Elpasso Farms’ and Cannabis Science’s initiatives in Africa in the areas of food security, collaborations, and economic development. The economic development initiatives presented include education, drug development, and job creation.
Cannabis Science and Elpasso Farms have recently entered into an agreement to develop a phytomedicines initiative in South Africa. This partnership will include establishing research, development, cultivation, testing, manufacturing, and production facilities. Additionally, CBIS and Elpasso intend to establish the Pan-African Agriculture and Commerce University (PAACU), which will serve as a platform for research, drug development, education, and training throughout Africa.
Additionally, Cannabis Science, Elpasso Farms, and Harvard Medical School’s GHC recently announced the signing of a historic collaboration agreement to develop initiatives throughout
GHC 2017
April 2017, the Cannabis Science team participated in the 2017 Global Health Catalyst Summit held at Harvard Medical School in Boston, MA. Mr. Dabney was the keynote speaker and panelist for a special session on “Cannabis Science Versus Cancer and Other Malignancies”.
Mr. Dabney discussed how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science’s vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research.
Additionally, Mr. Dabney presented summit participants with an overview of the company's drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). Dr. Allen Herman, Chief Medical Officer (CMO) of CBIS, Inc. Co-Chaired this session and participated in the discussion on the epidemiology of cancer and the utilization of opioids in Africa, which reflects the pain divide. Mr. Dabney and Dr. Herman lead CBIS’ collaboration with DFCI.
June 1, 2025, Pre-Launch Success! Click the below Image link to setup your Account and begin your Crypto Journey with us. All Crypto Coin Buyers receive a Limited Time Pre-Launch offer! The Time is Now.
1-Million Strong Killing Cancers!
Click the Below Image to Review our Cancer Drug Comparables
*** Warning this document contains graphic images.
CSi-VIP Awards & NASDAQ Updates
Please Click the Below Image:
The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.
Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.
We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.
Click here to review the Report:
Case No. 2:17-CV-02271-KJM-JDP
Inspire, Dream, Change
YOUR DIGITAL ERA Personal & Business Access Learning HUB
Click the above Image link to view the latest cancer Killing promotional video. This is where you can join our 1-Million Strong youtube page to view more videos as we proceed forward.
June 1, 2025, Pre-Launch Success
Click the above Image link to setup your Account and begin your Crypto Journey with us. All Crypto Coin Buyers receive a Limited Time offer!
*** Warning this document contains exciting images.
Pease Click the Calendar image to book your time to speak with Mr. Dabney about "Your Final CSi-VIP Shareholder Legacy".
The FINAL “CBIS GIFT Shares” Issuances!
DECEMBER 2024, Cheers! & HAPPY HOLIDAYS !!!
ALL GIFT Shares 1, 2, & 3 being ISSUED !!!
LAST Steps:
Please confirm Yours NOW !!!
1. CONFIRM Correct Total Share Amount(s)
2. CONFIRM Correct Name(s) on CERTIFICATE
3. CONFIRM Correct Mailing Address
ASU/CSi-EDP-ECO-System
At it's FINEST !!!
WHICH ONE ARE YOU ??
Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???
We can make this HAPPEN way FASTER Working as a TEAM !!!
WHAT Matters is how much you CARE about KILLING CANCERS ...
This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.
2025 Audit considerations NASDAQ.
Cannabis Science Inc.
Share Structure 2025
Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.
Common Stock:
Authorized:
5,000,000,000
Issued:
2,839,095,296
Fully Diluted:
4,510,547,648
Class A Common Stock
Authorized:
100,000,000
Issued:
0
Class B Common Stock
Authorized:
1,500,000,000
Issued:
0
Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000
Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.
You already know our Extensive LIST of GROUNDBREAKING Products.
1-Million STRONG TV Coverage, HARVARD Award Success.
TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE
*** APPLY for FREE in CONFIDENCE and Success.
Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.
EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!
Happy Father's Day! Wishing EVERYONE a Great relaxing day! It's certainly been a long road to recovery, but we won't stop till we get there (all our...Happy Father's Day! Wishing EVERYONE a Great relaxing day! It's certainly been a long road to recovery, but we won't stop till we get there (all our shares back trading again) and we are closer than ever now. Masks off & Fight as One! 1-Million Strong Killing Cancers! Cheers to Everyone!
God Bless us ALL.
Raymond - IGWT
Show more
CONGRATULATIONS Guys! We are about to go LIVE! We are launching a very exciting New Chapter in our Journey! We are launching a very ambitious...CONGRATULATIONS Guys! We are about to go LIVE! We are launching a very exciting New Chapter in our Journey! We are launching a very ambitious TV/Podcast Campaign with the "1-Million Strong Killing Cancers Fight Club" initiative.
Here’s a concise Summary of the key points:
We all know that Cancer disease is running rampant through our lives, and Cancer Treatment prices have run up just as fast. It seems we have all had people in our lives who has had a Battle with Cancer, family, friends or neighbors, and it has affected our Lives dramatically in most cases. We have a common Goal; to Keep Killing Cancers and get these Low-cost Cancer Killing drugs on the market now for those who need it most, right now.
That is why we created the 1-Million Strong Killing Cancers Fight Club. It’s time for us all to come together as one and Join in this Battle to Keep Killing Cancers. Well, we Won, we killed a few Cancers and took it all the way to HARVARD. We proved it works through 4-5 years of rigorous pre-clinical work and ended up with HARVARD giving us the Prestigious Industry Leader Award, and now it’s time to take it to the people who need it the most:
Main Highlights:
• Launch Plans: We are going Hard with Worldwide streaming TV/Podcast and Radio simulcast across multiple platforms, including major streaming services. To begin, our first 5 Episodes will air on Apple TV & iPhone, Android Phone & TV and Box, Roku, Amazon FireStick & FireTV, the App Store, Google Play, Alexa, iHeart, Spotify, PodBean, YouTube, Facebook, Instagram, TikTok, Google Podcast, Podcast addict, Castbox, PodChaser, Deezer, Stitcher, Spreaker, Audible, Podbay, Audio Junkie, Luminary, Podplay, and even more to come … with Platform Syndication, Archive Episodes, outstanding Reach, DISTRIBUTION – SYNDICATION – PRODUCTION, Commercials - Reviews - Content Distribution - On Demand - & Pay Per View – We’ve got REACH !!! The goal is to reach over 500 million people worldwide, with an initial 1.5 million+ listeners and viewers on Day One.
• Content: The first 5 episodes will highlight the journey to HARVARD and the fight against cancer, featuring our story and mission to develop and distribute low-cost cancer-killing drugs. The episodes will cover the Journey up to the present day, emphasizing the broader battle against cancer and encouraging people to join the cause through the ASU/CSi-EDP, 1-Million Strong Killing Cancers Fight Club “Make that Change” Campaign.
• Growth and Membership: The initiative aims to grow rapidly and attract 1 million members to the "1-Million Strong Killing Cancers Fight Club," which will play a role in pushing forward the FDA approval for these cancer-fighting treatments and bring our CBIS shares back to trade again. We will also focus on new ASU/CSi-EDP Partnerships with more companies like EBYH, Thermic, Live Negotiator, LMG Entertainment, ASU and many more to help expand the effort.
• Mission and Focus: The ultimate goal is to distribute low-cost cancer-killing drugs to people who need them most. This initiative focuses on empowering people to be part of the solution, leveraging the power of a massive community to drive progress and support the FDA approval process.
• Call to Action: We are encouraging you the people to sign up and join the movement, emphasizing the importance of becoming a member of the "1-Million Strong Killing Cancers Fight Club" to support the cause and gain access to various Events, opportunities, perks, and privileges. The mission is framed as a collective effort for the people, by the people to keep killing cancers.
Conclusion:
Our 1-Million Strong Killing Cancers campaign is aiming to make a significant impact, with a clear focus on expanding the membership, growing awareness, creating opportunities for its members and ultimately securing FDA approval for low-cost cancer treatments. The streaming TV/Podcast Mini-Series will roll out simulcast, with its broad reach, this is a major step in achieving these goals. The excitement and drive to involve the audience in the journey are central to the message, encouraging everyone to be a part of something larger than themselves.
This is TV/Podcast Mini-Series is a full-circle ride with us to HARVARD and back for the World to see! Encouraging everyone to Join the 1-Million Strong Killing Cancers Fight Club and push forward the “Battle to Make that Change” and get our Low-cost Cancer Killing Drugs through the FDA for the people.
The links are there for you to Join in now! The first 1-Million Members get a one-time $20.00 lifetime Membership! and Don’t forget to read our 1-Million Strong Killing Cancers Fight Club Media Kit and our CBIS/HARVARD Cancer Killing Research Reports to understand our Journey to HARVARD and back. Join in now and Hopefully we’ll see you at the 1-Million Strong Killing Cancers VIP Fundraiser Event in Miami, Florida, date and venue to be announced early 2025!
Investors and CSi-Shareholders are welcome to contact me directly for additional investment, CSi-VIP Status, and Partnership opportunities in the Cancer Drug itself and the ASU/CSi-EDP Partner Companies.
1-Million Strong, We are Killing Cancers!
We need you to Join the BATTLE now!
We are Underway! and we are Pumped!
Thanks again for All your Support.
Talk soon.
All the Best!
Raymond – IGWT
raymond.dabney@cannabisscience.com
Show more